This Medical News feature examines the debate about the value of frequent testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Michael MinaCan frequent rapid testing stop COVID-19?
I think it will... if we make them. If we had them two months ago, we could be in a very different position
A dive into the details: barriers, pitfalls and benefits by @RitaRubinja.ma/37sFLoX via @JAMA_current
Severe acquired respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of coronavirus disease (COVID-19). In severe COVID-19 cases, higher antibody titers against seasonal coronaviruses have been observed than in mild cases. To investigate...
For most people, COVID-19 test entails a swab up the nose in a doctor’s office or at a drive-in site. The sample then goes out to a lab. Results come back within a few days to a week—a waiting period that’s simply too long to stop the spread of the...
The average wait time for results of a coronavirus test has dropped to about three days, but that is still too slow to keep infected people from unknowingly spreading the virus, researchers report.
Michael MinaTesting delays still far too long to help contain #COVID19:
‘The average White, Asian-American, Hispanic, or Black respondent waited 5.7, 6.1, 6.9, and 7.4 days respectively’
We need different, faster, frequent accessible rapid tests.
This can’t work
Natural killer (NK) cells are heterogeneous innate effector cells, with some NK subsets displaying features of adaptive immunity including memory and antigen specificity. Because liver NK cells are enriched for adaptive NK cells, Stary et al. used...
Michael MinaNew study providing yet another link between innate and adaptive immunity. Here, honing in on memory committed natural killer cells with specificity for discrete antigens. Information that will create new opportunity for immune therapies and vaccines
An open letter expresses dismay at the nation’s public-health response to the Covid-19 pandemic and calls for the federal agency to play a more central role.
Michael MinaThis is fairly incredible.
At some point, enough truly becomes enough and even the muzzled begin to speak out, even if it means their careers.
Good for you @CDCgov current and former people willing to condemn the (lack of) efforts to date.
In a small study in San Francisco, Abbott’s BinaxNOW identified infectious people nearly as accurately as a P.C.R. test.
Michael MinaNEW! research shows rapid antigen tests can work in a real world setting - with asymptomatic and symptomatic people. The rapid "paper-strip" antigen test called the BinaxNOW detected >90% of people with high viral loads who are likely to be infectious